Physician profile
Mark D Suski
NPI 1093886731
$294,323.92
in general payments reported to CMS, 2019-2025
30 companies · $92K in 2025
The $92K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $6,362 · 2021: $1,447 · 2022: $5,622 · 2023: $103K · 2024: $61K · 2025: $92K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $157K · Travel and Lodging: $42K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Consulting Fee: $17K · Food and Beverage: $8,917 · Education: $5,678 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $157,000.00 |
| Travel and Lodging | $42,023.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,551.00 |
| Consulting Fee | $17,450.00 |
| Food and Beverage | $8,917.43 |
| Education | $5,678.20 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $239,563.26 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Urgo Medical North America, LLC | $17,106.00 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Urgoclean Ag |
| Kci USA, INC. | $14,741.45 | 2019-2023 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
| Smith+Nephew, INC. | $5,602.54 | 2019-2025 | Grafix, Grafix Pl, Oasis |
| Aroa Biosurgery Incorporated | $3,685.67 | 2024-2025 | |
| Ets Wound Care LLC | $3,639.05 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Biotissue Holdings INC. | $2,920.29 | 2019-2024 | |
| Next Science LLC | $1,883.43 | 2021-2022 | |
| Royal Biologics, INC. | $889.33 | 2025 | |
| Acera Surgical, INC. | $822.80 | 2022-2024 | Restrata Wound Matrix |
| Amniox Medical, INC. | $682.56 | 2019 | |
| Sanara Medtech INC. | $597.97 | 2021-2022 | |
| Organogenesis INC. | $298.63 | 2019-2024 | Nushield |
| Ethicon US, LLC | $253.08 | 2022-2025 | Vistaseal, Surgiflo Hemostatic Matrix, Evarrest |
| Integra Lifesciences Corporation | $249.97 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $178.70 | 2019-2022 | |
| Intuitive Surgical, INC. | $148.95 | 2019 | |
| Abbvie INC. | $134.98 | 2021 | |
| Medical Device Business Services, INC. | $125.00 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $124.99 | 2021 | |
| Grifols USA, LLC | $124.99 | 2021 | |
| Osiris Therapeutics INC. | $123.25 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $94.09 | 2021 | |
| Paratek Pharmaceuticals, INC. | $70.97 | 2024-2025 | Nuzyra |
| Mimedx Group, INC. | $70.59 | 2025 | |
| Medtronic, INC. | $63.07 | 2021-2023 | Arctic Front Advance |
| Access Pro Medical, LLC | $55.56 | 2025 | Matriderm |
| Tactile Systems Technology INC | $41.67 | 2019-2021 | |
| Bsn Medical INC | $16.75 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Suski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.